ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 143 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,122,000 | +131.8% | 91,600 | +116.5% | 0.34% | +148.2% |
Q2 2017 | $484,000 | -36.6% | 42,300 | +15.3% | 0.14% | -44.1% |
Q1 2017 | $763,000 | +19.4% | 36,700 | +88.2% | 0.24% | +3.4% |
Q3 2016 | $639,000 | +160.8% | 19,500 | +99.0% | 0.24% | +189.0% |
Q2 2016 | $245,000 | – | 9,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |